Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years

Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 11.29% on an annualized basis producing an average annual return of 18.54%. Currently, Regeneron Pharmaceuticals has a market capitalization of $77.02 billion.

Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $30,533.78 today based on a price of $709.61 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 20 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.